HIV Prevention in Women: ACOG urges ob/gyns to use routine visits for nonjudgmental sexual histories and at least one lifetime HIV test (ages 15–65), and to counsel on PrEP to cut barriers to prevention. Ebola Vaccine Push: Moderna starts a Phase 1 trial of its mRNA-1469 Bundibugyo Ebola vaccine in Canada, backed by CEPI, aiming to speed toward larger trials if early results hold. Ebola Outbreak Warning: Africa CDC says contact tracing is failing in eastern Congo’s Bundibugyo outbreak, with community spread driving new cases and no licensed vaccine or targeted treatment. Cancer Care Advances: FDA clears BlueWind Medical’s Revi Extend implantable tibial neuromodulation for urgency urinary incontinence, extending implant life to 15 years; Summit Therapeutics launches a global Phase 2/3 trial combining ivonescimab with enfortumab vedotin for first-line urothelial cancer. AI-Enabled Pathology Quality: Leeds NHS innovation TANGO helps standardize cancer slide staining to improve consistency for digital pathology and AI diagnostics. Healthcare Access Under Strain: Report warns Israel’s policies are pushing West Bank healthcare toward collapse, leaving patients unable to get basic medicines and services. Public Health Alerts: Los Angeles issues a measles exposure alert after an infected visitor spent 11 hours at Universal Studios Hollywood; the US also flags rising dengue risk in Kenya for travelers. Global Dealmaking: KKR signs to acquire Medicover India in a ~$1.5B deal, expanding a 24-hospital network across South and West India.